Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark H Greene

Showing results (11-20 of 219) with videos related to

Pageof 22
Sort By:
Journal of the National Cancer Institute|March 13, 2018
Testing Positive on a Multigene Panel Does Not Suffice to Determine Disease RisksHormuzd A Katki, Mark H Greene, Maria Isabel Achatz
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 2, 2014
A major step forward for BRCA1/2-related cancer risk managementPhuong L Mai, Jennifer T Loud, Mark H Greene
The Lancet. Oncology|December 7, 2007
Breast-cancer risk in BRCA-mutation-negative women from BRCA-mutation-positive familiesHormuzd A Katki, Mitchell H Gail, Mark H Greene
Best Practice & Research. Clinical Endocrinology & Metabolism|September 14, 2010
Familial testicular germ cell tumoursChristian P Kratz, Phuong L Mai, Mark H Greene
Families, Systems & Health : the Journal of Collaborative Family Healthcare|March 21, 2012
Toward a new understanding of risk perception among young female BRCA1/2 "previvors"Lindsey M Hoskins, Kevin M Roy, Mark H Greene
Blood|October 24, 2002
Cancer incidence in persons with Fanconi anemiaPhilip S Rosenberg, Mark H Greene, Blanche P Alter
Plos One|March 4, 2014
In their own words: treating very young BRCA1/2 mutation-positive women with care and cautionLindsey M Hoskins, Allison Werner-Lin, Mark H Greene
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 4, 2015
Reply to m.j. Mourits et AlMark E Sherman, Marion Piedmonte, Phuong L Mai, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 16, 2012
Potential usefulness of single nucleotide polymorphisms to identify persons at high cancer risk: an evaluation of seven common cancersJu-Hyun Park, Mitchell H Gail, Mark H Greene, et al.
Cancer Epidemiology|August 15, 2009
A mini-review of familial ovarian germ cell tumors: an additional manifestation of the familial testicular germ cell tumor syndromeClaudia Giambartolomei, Christine M Mueller, Mark H Greene, et al.
Pageof 22

Showing results (11-20 of 219) with videos related to

Sort By:
Pageof 22
Journal of the National Cancer Institute|March 13, 2018
Testing Positive on a Multigene Panel Does Not Suffice to Determine Disease RisksHormuzd A Katki, Mark H Greene, Maria Isabel Achatz
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 2, 2014
A major step forward for BRCA1/2-related cancer risk managementPhuong L Mai, Jennifer T Loud, Mark H Greene
The Lancet. Oncology|December 7, 2007
Breast-cancer risk in BRCA-mutation-negative women from BRCA-mutation-positive familiesHormuzd A Katki, Mitchell H Gail, Mark H Greene
Best Practice & Research. Clinical Endocrinology & Metabolism|September 14, 2010
Familial testicular germ cell tumoursChristian P Kratz, Phuong L Mai, Mark H Greene
Families, Systems & Health : the Journal of Collaborative Family Healthcare|March 21, 2012
Toward a new understanding of risk perception among young female BRCA1/2 "previvors"Lindsey M Hoskins, Kevin M Roy, Mark H Greene
Blood|October 24, 2002
Cancer incidence in persons with Fanconi anemiaPhilip S Rosenberg, Mark H Greene, Blanche P Alter
Plos One|March 4, 2014
In their own words: treating very young BRCA1/2 mutation-positive women with care and cautionLindsey M Hoskins, Allison Werner-Lin, Mark H Greene
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 4, 2015
Reply to m.j. Mourits et AlMark E Sherman, Marion Piedmonte, Phuong L Mai, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 16, 2012
Potential usefulness of single nucleotide polymorphisms to identify persons at high cancer risk: an evaluation of seven common cancersJu-Hyun Park, Mitchell H Gail, Mark H Greene, et al.
Cancer Epidemiology|August 15, 2009
A mini-review of familial ovarian germ cell tumors: an additional manifestation of the familial testicular germ cell tumor syndromeClaudia Giambartolomei, Christine M Mueller, Mark H Greene, et al.
Pageof 22